Since the success of maternal immunization relies on the same principles, the evaluation of the efficacy of active DNA maternal immunization against neu has recently been performed in order to hamper spontaneous mammary tumor progression in BALB-neuT offspring [148]. Here, ERBB2 is linked to breast cancer.